Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001577043 | SCV001804360 | uncertain significance | not provided | 2019-03-28 | criteria provided, single submitter | clinical testing | The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014; Hart et al., 2002); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002343752 | SCV002621205 | uncertain significance | Cardiovascular phenotype | 2021-06-01 | criteria provided, single submitter | clinical testing | The p.N1246S variant (also known as c.3737A>G), located in coding exon 23 of the SOS1 gene, results from an A to G substitution at nucleotide position 3737. The asparagine at codon 1246 is replaced by serine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV002468277 | SCV002763542 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002468276 | SCV002763543 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV002570808 | SCV003514178 | benign | RASopathy | 2023-04-28 | criteria provided, single submitter | clinical testing |